Question 1: Which of the following conditions is characterized by an abnormal electrical pathway in the heart that can lead to rapid heartbeats?
A. Atrial Fibrillation
B. Ventricular Tachycardia
C. Wolff-Parkinson-White (WPW) Syndrome
D. Sinus Bradycardia
E. Long QT Syndrome
Click here to see the answer
Answer: C. Wolff-Parkinson-White (WPW) Syndrome
Explanation: WPW syndrome is caused by an accessory pathway (Kent bundle) that bypasses the normal conduction system, leading to episodes of rapid heartbeats.
Question 2: What is the definitive treatment for Wolff-Parkinson-White (WPW) syndrome that often cures the condition?
A. Medications
B. Vagal Maneuvers
C. Electrical Cardioversion
D. Catheter Ablation
E. Surgery
Click here to see the answer
Answer: D. Catheter Ablation
Explanation: Catheter ablation is a minimally invasive procedure that destroys the accessory pathway, curing WPW syndrome in most cases.
Question 3: Which of the following arrhythmias is classified as a ventricular arrhythmia?
A. Atrial Fibrillation
B. Ventricular Tachycardia
C. Sinus Bradycardia
D. Supraventricular Tachycardia
E. Atrial Flutter
Click here to see the answer
Answer: B. Ventricular Tachycardia
Explanation: Ventricular Tachycardia (VT) originates from the ventricles and is a type of ventricular arrhythmia, which can be life-threatening.
Question 4: Which of the following is an atrial arrhythmia characterized by irregular and often rapid heart rate?
A. Ventricular Fibrillation
B. Long QT Syndrome
C. Atrial Fibrillation
D. Premature Ventricular Contractions
E. Heart Block
Click here to see the answer
Answer: C. Atrial Fibrillation
Explanation: Atrial Fibrillation (AFib) is an atrial arrhythmia characterized by an irregular and often rapid heart rate originating in the atria.
Question 5: Which type of heart block is characterized by a complete block of the heart’s electrical impulses?
A. First-degree heart block
B. Second-degree heart block Type I
C. Second-degree heart block Type II
D. Third-degree heart block
E. Sinus Bradycardia
Click here to see the answer
Answer: D. Third-degree heart block
Explanation: Third-degree heart block, or complete heart block, is characterized by a complete block of the heart’s electrical impulses, preventing any impulses from the atria to reach the ventricles.
Question 6: Which arrhythmia is typically treated with techniques like bearing down or rubbing the neck to slow down the heart rate during an episode?
A. Supraventricular Tachycardia (SVT)
B. Ventricular Fibrillation (VFib)
C. Atrial Flutter
D. Long QT Syndrome
E. Premature Atrial Contractions (PACs)
Click here to see the answer
Answer: A. Supraventricular Tachycardia (SVT)
Explanation: Supraventricular Tachycardia (SVT) is often treated with vagal maneuvers, such as bearing down or rubbing the neck, to slow down the heart rate during an episode.
Question 7: Which type of arrhythmia is caused by rapid and irregular heartbeats originating in the ventricles and is a medical emergency?
A. Atrial Fibrillation
B. Ventricular Fibrillation
C. Sinus Bradycardia
D. Atrial Flutter
E. Premature Atrial Contractions
Click here to see the answer
Answer: B. Ventricular Fibrillation
Explanation: Ventricular Fibrillation (VFib) is characterized by rapid and irregular heartbeats originating in the ventricles and is a medical emergency requiring immediate treatment.
Question 8: Which of the following antiarrhythmic drugs is classified as a Class III agent?
A) Propranolol
B) Lidocaine
C) Amiodarone
D) Verapamil
E) Digoxin
Click here to see the answer
Correct Answer: C) Amiodarone
Explanation: Class III antiarrhythmic drugs work by prolonging the action potential duration and the refractory period in cardiac tissues. Amiodarone is a well-known Class III agent. Propranolol (Class II), Lidocaine (Class IB), Verapamil (Class IV), and Digoxin (miscellaneous) are not Class III agents.
Question 9: Which of the following is a characteristic effect of Class I antiarrhythmic drugs?
A) Increase in the heart rate
B) Blockade of calcium channels
C) Sodium channel blockade
D) Potassium channel blockade
E) Stimulation of beta receptors
Click here to see the answer
Correct Answer: C) Sodium channel blockade
Explanation: Class I antiarrhythmic drugs primarily function by blocking sodium channels, which slows down the depolarization of the cardiac cells, affecting the action potential and conduction velocity. This class is further subdivided into IA, IB, and IC based on their effects on the action potential duration.
Question 10: Which antiarrhythmic drug is correctly matched with its classification?
A) Quinidine – Class IB
B) Atenolol – Class III
C) Sotalol – Class III
D) Diltiazem – Class I
E) Mexiletine – Class IV
Click here to see the answer
Correct Answer: C) Sotalol – Class III
Explanation: Sotalol is classified as a Class III antiarrhythmic drug because it prolongs the action potential duration by blocking potassium channels. Quinidine is Class IA, Atenolol is Class II, Diltiazem is Class IV, and Mexiletine is Class IB.
Question 11: Which class of antiarrhythmic drugs is known for blocking beta-adrenergic receptors?
A) Class I
B) Class II
C) Class III
D) Class IV
E) Class V
Click here to see the answer
Correct Answer: B) Class II
Explanation: Class II antiarrhythmic drugs, also known as beta-blockers, act by blocking beta-adrenergic receptors. This action reduces heart rate, decreases myocardial contractility, and reduces conduction velocity through the AV node, making them effective in treating arrhythmias associated with high sympathetic activity.
Question 12: Which of the following antiarrhythmic drugs is classified as a Class IV agent?
A) Flecainide
B) Metoprolol
C) Dofetilide
D) Verapamil
E) Procainamide
Click here to see the answer
Correct Answer: D) Verapamil
Explanation: Class IV antiarrhythmic drugs are calcium channel blockers that work by inhibiting calcium influx into cardiac cells, particularly in the AV node. Verapamil is a classic example of a Class IV agent. Flecainide (Class IC), Metoprolol (Class II), Dofetilide (Class III), and Procainamide (Class IA) are not Class IV agents.
Question 13: Which laboratory test is essential in the management of a patient suspected of digoxin toxicity?
A) Serum magnesium levels
B) Serum creatinine levels
C) Serum digoxin levels
D) Serum cholesterol levels
E) Serum thyroid-stimulating hormone (TSH) levels
Click here to see the answer
Correct Answer: C) Serum digoxin levelsExplanation: Measuring serum digoxin levels is essential in the management of a patient suspected of digoxin toxicity. Elevated levels can confirm toxicity and guide appropriate treatment, such as the use of digoxin-specific antibody fragments.
Question 14: What is the primary mechanism of action of digoxin?
A) Inhibition of beta-adrenergic receptors
B) Inhibition of sodium-potassium ATPase
C) Activation of calcium channels
D) Blockade of sodium channels
E) Stimulation of alpha-adrenergic receptors
Click here to see the answer
Correct Answer: B) Inhibition of sodium-potassium ATPase
Explanation: Digoxin works primarily by inhibiting the sodium-potassium ATPase enzyme in cardiac cells. This inhibition leads to an increase in intracellular sodium levels, which subsequently increases intracellular calcium levels, enhancing cardiac contractility.
Question 15: Which of the following is a therapeutic use of digoxin?
A) Hypertension
B) Chronic obstructive pulmonary disease (COPD)
C) Atrial fibrillation
D) Asthma
E) Diabetes mellitus
Click here to see the answer
Correct Answer: C) Atrial fibrillation
Explanation: Digoxin is used therapeutically to treat atrial fibrillation and heart failure. It helps control the heart rate in atrial fibrillation and improves symptoms in heart failure by increasing the force of myocardial contraction.
Question 16: Which of the following is a common side effect of digoxin?
A) Hyperkalemia
B) Hypokalemia
C) Bradycardia
D) Tachycardia
E) Hypertension
Click here to see the answer
Correct Answer: C) Bradycardia
Explanation: A common side effect of digoxin is bradycardia, or a slow heart rate. This occurs because digoxin increases vagal (parasympathetic) activity, which slows down the conduction through the AV node and reduces the heart rate.
Question 17: Which symptom is indicative of digoxin toxicity?
A) Increased appetite
B) Visual disturbances (e.g., yellow-green halos)
C) Hypertension
D) Diarrhea
E) Weight gain
Click here to see the answer
Correct Answer: B) Visual disturbances (e.g., yellow-green halos)
Explanation: Visual disturbances, such as yellow-green halos around objects, are a classic symptom of digoxin toxicity. Other symptoms can include nausea, vomiting, confusion, and cardiac arrhythmias.
Question 18: What is the initial management step in the case of acute digoxin toxicity?
A) Administering intravenous calcium
B) Administering digoxin-specific antibody fragments (Digi Fab)
C) Performing dialysis
D) Administering beta-blockers
E) Administering sodium bicarbonate
Click here to see the answer
Correct Answer: B) Administering digoxin-specific antibody fragments (Digi Fab)
Explanation: The initial management of acute digoxin toxicity often involves the administration of digoxin-specific antibody fragments (digoxin immune Fab), which bind to digoxin and neutralize its effects. Other supportive measures may also be necessary, depending on the patient’s condition.
Question 19: Which of the following electrolyte imbalances can exacerbate digoxin toxicity?
A) Hypernatremia
B) Hypocalcemia
C) Hypermagnesemia
D) Hypokalemia
E) Hyperchloremia
Click here to see the answer
Correct Answer: D) Hypokalemia
Explanation: Hypokalemia can exacerbate digoxin toxicity because low potassium levels increase digoxin’s binding to the sodium-potassium ATPase, enhancing its effects and increasing the risk of toxicity.
Question 20: Digoxin is most commonly used in the management of which of the following conditions?
A) Acute myocardial infarction
B) Hyperthyroidism
C) Heart failure with reduced ejection fraction
D) Peripheral artery disease
E) Chronic kidney disease
Click here to see the answer
Correct Answer: C) Heart failure with reduced ejection fraction
Explanation: Digoxin is commonly used in the management of heart failure with reduced ejection fraction. It helps improve symptoms by increasing the force of myocardial contraction and promoting a more effective heart pump.
Question 21: Which of the following is a potential side effect of digoxin related to the gastrointestinal system?
A) Constipation
B) Diarrhea
C) Gastric ulcer
D) Nausea and vomiting
E) Hepatomegaly
Click here to see the answer
Correct Answer: D) Nausea and vomiting
Explanation: Nausea and vomiting are common gastrointestinal side effects of digoxin. These symptoms can indicate toxicity, especially if they occur alongside other signs such as visual disturbances or arrhythmias.
Question 22: How does digoxin primarily increase cardiac contractility?
A) By increasing myocardial oxygen consumption
B) By stimulating beta-adrenergic receptors
C) By increasing intracellular calcium levels
D) By blocking potassium channels
E) By decreasing intracellular sodium levels
Click here to see the answer
Correct Answer: C) By increasing intracellular calcium levels
Explanation: Digoxin increases cardiac contractility by inhibiting the sodium-potassium ATPase pump, leading to an increase in intracellular sodium levels. This, in turn, decreases the activity of the sodium-calcium exchanger, resulting in higher intracellular calcium levels, which enhances myocardial contractility.
Question 23: Which of the following is NOT a symptom of digoxin toxicity?
A) Confusion
B) Hypercalcemia
C) Bradycardia
D) Visual disturbances
E) Nausea
Click here to see the answer
Correct Answer: B) Hypercalcemia
Explanation: Hypercalcemia is not typically associated with digoxin toxicity. Common symptoms of digoxin toxicity include confusion, bradycardia, visual disturbances (such as yellow-green halos), and gastrointestinal symptoms like nausea and vomiting.
Question 24: A 68-year-old male patient with a history of chronic heart failure and atrial fibrillation presents to the emergency department with complaints of nausea, vomiting, and seeing yellow-green halos around lights. He has been on digoxin therapy for the past six months. On examination, his pulse is noted to be 48 beats per minute, and an ECG shows bradycardia.
Question 24.1: What is the most likely diagnosis for this patient?
A) Acute myocardial infarction
B) Hypokalemia
C) Digoxin toxicity
D) Hyperthyroidism
E) Gastroenteritis
Click here to see the answer
Correct Answer: C) Digoxin toxicity
Explanation: The patient’s symptoms of nausea, vomiting, visual disturbances (yellow-green halos), and bradycardia, along with a history of digoxin use, are indicative of digoxin toxicity.
Question 24.2: What is the most appropriate initial management step for this patient?
A) Administer intravenous potassium
B) Start hemodialysis
C) Administer digoxin-specific antibody fragments (digoxin immune Fab)
D) Administer beta-blockers
E) Perform gastric lavage
Click here to see the answer
Correct Answer: C) Administer digoxin-specific antibody fragments (digoxin immune Fab)
Explanation: The most appropriate initial management step for a patient with suspected digoxin toxicity is the administration of digoxin-specific antibody fragments (digoxin immune Fab), which bind to digoxin and neutralize its effects. Other supportive measures and monitoring of electrolyte levels, particularly potassium, are also important.
Question 25: What does the P wave represent in an electrocardiogram (ECG)?
A) Ventricular depolarization
B) Atrial depolarization
C) Ventricular repolarization
D) Atrial repolarization
E) Interval between ventricular depolarization and repolarization
Click here to see the answer
Correct Answer: B) Atrial depolarization
Explanation: The P wave on an ECG represents atrial depolarization, which is the electrical activity associated with the contraction of the atria.
Question 26: Which interval on the ECG represents the period from the onset of atrial depolarization to the onset of ventricular depolarization?
A) QT Interval
B) ST Segment
C) PR Interval
D) QRS Complex
E) U Wave
Click here to see the answer
Correct Answer: C) PR Interval
Explanation: The PR interval on an ECG represents the time from the onset of atrial depolarization to the onset of ventricular depolarization. It includes the P wave and the PR segment.
Question 27: What is indicated by the QRS complex on an ECG?
A) Atrial depolarization
B) Atrial repolarization
C) Ventricular depolarization
D) Ventricular repolarization
E) Interval between ventricular depolarization and repolarization
Click here to see the answer
Correct Answer: C) Ventricular depolarization
Explanation: The QRS complex represents ventricular depolarization, which is the electrical activity associated with the contraction of the ventricles.
Question 28: What does the ST segment represent in an ECG?
A) Atrial depolarization
B) Atrial repolarization
C) Ventricular depolarization
D) Interval between ventricular depolarization and repolarization
E) Ventricular repolarization
Click here to see the answer
Correct Answer: D) Interval between ventricular depolarization and repolarization
Explanation: The ST segment represents the interval between the end of ventricular depolarization and the beginning of ventricular repolarization. It is typically a flat, isoelectric segment.
Question 29: Which part of the ECG represents ventricular repolarization?
A) P Wave
B) PR Interval
C) QRS Complex
D) T Wave
E) U Wave
Click here to see the answer
Correct Answer: D) T Wave
Explanation: The T wave on an ECG represents ventricular repolarization, which is the process by which the ventricles return to their resting state after depolarization.
Question 30: What does the QT interval on an ECG signify?
A) Atrial depolarization to atrial repolarization
B) Ventricular depolarization to the end of ventricular repolarization
C) Interval between ventricular depolarization and repolarization
D) Onset of atrial depolarization to onset of ventricular depolarization
E) Atrial repolarization
Click here to see the answer
Correct Answer: B) Ventricular depolarization to the end of ventricular repolarization
Explanation: The QT interval represents the period from the beginning of ventricular depolarization to the end of ventricular repolarization, encompassing both the QRS complex and the T wave.
Question 31: Which wave on an ECG may sometimes be present after the T wave and represents further repolarization?
A) P Wave
B) PR Interval
C) QRS Complex
D) ST Segment
E) U Wave
Click here to see the answer
Correct Answer: E) U Wave
Explanation: The U wave may sometimes be present after the T wave and is thought to represent further repolarization of the ventricles or possibly repolarization of the Purkinje fibers.
Question 32: Which enzyme’s inhibition by amiodarone can increase the effects of other drugs such as statins and warfarin?
A) CYP2D6
B) CYP1A2
C) CYP3A4
D) CYP2C9
E) CYP2E1
Click here to see the answer
Correct Answer: C) CYP3A4
Explanation: Amiodarone is a potent inhibitor of CYP3A4. This inhibition can increase the levels and effects of drugs metabolized by CYP3A4, such as statins (leading to an increased risk of myopathy/rhabdomyolysis) and warfarin (leading to an increased anticoagulant effect).
Question 33: Which enzyme does amiodarone inhibit, potentially increasing the levels and effects of drugs metabolized by this enzyme?
A) CYP2D6
B) CYP3A4
C) CYP1A2
D) CYP2C9
E) CYP2E1
Click here to see the answer
Correct Answer: B) CYP3A4
Explanation: Amiodarone is a potent inhibitor of CYP3A4, which can increase the levels and effects of other drugs metabolized by this enzyme, such as statins, warfarin, and certain antiarrhythmics.
Question 34: What is a serious, but rare, side effect of amiodarone that can be potentially fatal?
A) Hyperkalemia
B) Hepatotoxicity
C) Pulmonary fibrosis
D) Nephrotoxicity
E) Thrombocytopenia
Click here to see the answer
Correct Answer: C) Pulmonary fibrosis
Explanation: Pulmonary fibrosis is a rare but serious side effect of amiodarone, which can be potentially fatal and requires careful monitoring.
Question 35: Which of the following monitoring steps is recommended annually for a patient on long-term amiodarone therapy?
A) Serum TSH
B) ECG
C) Chest X-ray
D) Liver Function Tests (LFTs)
E) Electrolyte levels
Click here to see the answer
Correct Answer: C) Chest X-ray
Explanation: An annual chest X-ray is recommended to monitor for pulmonary fibrosis in patients on long-term amiodarone therapy.
Question 36: Which of the following drug interactions with amiodarone requires careful monitoring due to an increased risk of toxicity?
A) Aspirin
B) Metformin
C) Digoxin
D) Ibuprofen
E) Lisinopril
Click here to see the answer
Correct Answer: C) Digoxin
Explanation: Amiodarone inhibits P-glycoprotein (P-gp), which can lead to increased levels of digoxin. This interaction increases the risk of digoxin toxicity, which can present as nausea, vomiting, and cardiac arrhythmias. Therefore, careful monitoring of digoxin levels and potential dose adjustments are necessary when co-administered with amiodarone.
Question 37: Which of the following symptoms is a common side effect of amiodarone related to eye health?
A) Increased intraocular pressure
B) Halos or blurred vision
C) Cataracts
D) Retinal detachment
E) Conjunctivitis
Click here to see the answer
Correct Answer: B) Halos or blurred vision
Explanation: Halos or blurred vision are common side effects of amiodarone, occurring in about 10% of patients, often due to corneal microdeposits.
Question 38: What effect does amiodarone have on the thyroid gland?
A) It can cause hyperthyroidism only
B) It can cause hypothyroidism only
C) It has no effect on thyroid function
D) It can cause both hypo- and hyperthyroidism
E) It increases T4 to T3 conversion
Click here to see the answer
Correct Answer: D) It can cause both hypo- and hyperthyroidism
Explanation: Amiodarone contains iodine and can affect thyroid function, potentially causing both hypo- and hyperthyroidism by interfering with T4 to T3 conversion.
Question 39: Which of the following drug interactions is NOT associated with amiodarone?
A) Increased risk of myopathy/rhabdomyolysis with statins
B) Increased anticoagulant effect with warfarin
C) Increased risk of toxicity with digoxin
D) Decreased efficacy of beta-blockers
E) Increased hypotension with sildenafil
Click here to see the answer
Correct Answer: D) Decreased efficacy of beta-blockers
Explanation: Amiodarone can increase the effects of beta-blockers, leading to increased bradycardia, AV block, and hypotension. It does not decrease their efficacy.
Question 40: Which of the following side effects of amiodarone can be detected using a slit-lamp eye exam?
A) Corneal microdeposits
B) Retinal detachment
C) Cataracts
D) Conjunctivitis
E) Macular degeneration
Click here to see the answer
Correct Answer: A) Corneal microdeposits
Explanation: Corneal microdeposits can be detected using a slit-lamp eye exam, a common side effect of amiodarone that may cause visual disturbances such as halos or blurred vision.
Question 41: Amiodarone can lead to blue-gray skin discoloration. This side effect is often associated with:
A) Short-term use
B) Interaction with sunlight
C) Lack of hydration
D) Hypersensitivity reaction
E) Use of other medications
Click here to see the answer
Correct Answer: B) Interaction with sunlight
Explanation: Blue-gray skin discoloration is often associated with long-term use of amiodarone and interaction with sunlight, due to photosensitivity.
Question 42: Which of the following is an important monitoring parameter for detecting potential liver damage in patients taking amiodarone?
A) Serum creatinine
B) Bilirubin levels
C) Liver function tests (LFTs)
D) Alkaline phosphatase
E) Blood urea nitrogen (BUN)
Click here to see the answer
Correct Answer: C) Liver function tests (LFTs)
Explanation: Regular monitoring of liver function tests (LFTs) is important for detecting potential liver damage in patients taking amiodarone.
Question 43: How often should serum TSH levels be monitored in patients on long-term amiodarone therapy?
A) Every month
B) Every 3 months
C) Every 6 months
D) Every year
E) Every 2 years
Click here to see the answer
Correct Answer: C) Every 6 months
Explanation: Serum TSH levels should be monitored every 6 months in patients on long-term amiodarone therapy to detect potential thyroid dysfunction, including hypo- and hyperthyroidism.
Question 44: What is the recommended frequency for performing an ECG in patients taking amiodarone?
A) Every month
B) Every 3 months
C) Every 6 months
D) Every year
E) Every 2 years
Click here to see the answer
Correct Answer: D) Every year
Explanation: An ECG should be performed annually in patients taking amiodarone to monitor for arrhythmias and QT prolongation.
Question 45: Amiodarone-induced pulmonary fibrosis can be monitored by which of the following methods?
A) Pulmonary function tests (PFTs)
B) Bronchoscopy
C) Chest X-ray
D) CT scan of the chest
E) Sputum culture
Click here to see the answer
Correct Answer: C) Chest X-ray
Explanation: An annual chest X-ray is recommended to monitor for amiodarone-induced pulmonary fibrosis, a serious and potentially fatal side effect.
Question 46: What cardiovascular effect should be closely monitored in patients taking amiodarone, especially when combined with beta-blockers or calcium channel blockers?
A) Tachycardia
B) Bradycardia
C) Hypertension
D) Myocardial infarction
E) Atrial fibrillation
Click here to see the answer
Correct Answer: B) Bradycardia
Explanation: Bradycardia is a cardiovascular effect that should be closely monitored in patients taking amiodarone, especially when combined with beta-blockers or calcium channel blockers, due to the risk of additive effects.
Question 47: Which electrolyte imbalance should be monitored to prevent arrhythmias in patients on amiodarone therapy?
A) Hypernatremia
B) Hyperkalemia
C) Hypomagnesemia
D) Hypokalemia
E) Hypercalcemia
Click here to see the answer
Correct Answer: D) Hypokalemia
Explanation: Hypokalemia should be monitored to prevent arrhythmias in patients on amiodarone therapy, as electrolyte imbalances can exacerbate the risk of arrhythmias.
Question 48: What is the significance of monitoring LFT transaminase levels in patients taking amiodarone?
A) To detect renal dysfunction
B) To assess liver function
C) To measure thyroid function
D) To monitor electrolyte balance
E) To evaluate cardiac output
Click here to see the answer
Correct Answer: B) To assess liver function
Explanation: Monitoring LFT transaminase levels is significant for assessing liver function in patients taking amiodarone, as the drug can cause hepatotoxicity.
Question 49: What is the recommended frequency for regular eye exams in patients on long-term amiodarone therapy?
A) Every month
B) Every 3 months
C) Every 6 months
D) Every year
E) Every 2 years
Click here to see the answer
Correct Answer: D) Every year
Explanation: Regular eye exams should be conducted annually in patients on long-term amiodarone therapy to monitor for eye problems such as corneal deposits and visual disturbances.
Question 50: Amiodarone can cause both hypo- and hyperthyroidism due to its effect on which process?
A) Decreasing TSH secretion
B) Increasing T4 to T3 conversion
C) Decreasing iodine uptake by the thyroid
D) Interfering with T4 to T3 conversion
E) Enhancing thyroid hormone receptor sensitivity
Click here to see the answer
Correct Answer: D) Interfering with T4 to T3 conversion
Explanation: Amiodarone can cause both hypo- and hyperthyroidism by interfering with the conversion of T4 to T3, due to its iodine content.
Amiodarone can cause both hypo- and hyperthyroidism due to its high iodine content and its effect on thyroid function. Specifically:
- Hypothyroidism: Amiodarone can inhibit the peripheral conversion of T4 (thyroxine) to T3 (triiodothyronine), leading to decreased T3 levels.
- Hyperthyroidism: Amiodarone can cause thyroiditis or increased thyroid hormone production due to the excess iodine (the Jod-Basedow phenomenon).